# Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

> **NCT00654160** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 7 (actual)

## Conditions studied

- Anal Cancer
- Carcinoma of the Appendix
- Colorectal Cancer
- Esophageal Cancer
- Extrahepatic Bile Duct Cancer
- Gallbladder Cancer
- Gastric Cancer
- Gastrointestinal Carcinoid Tumor
- Gastrointestinal Stromal Tumor
- Liver Cancer
- Pancreatic Cancer
- Small Intestine Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** irinotecan hydrochloride
- **DRUG:** leucovorin calcium
- **OTHER:** pharmacogenomic studies
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00654160
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-11
- **Final completion:** 2012-12-03
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2017-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654160, "Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00654160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*